Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for shares of Moderna in a note issued to investors ...

J.P. Morgan analyst Jessica Fye has maintained their bearish stance on MRNA stock, giving a Sell rating yesterday.Stay Ahead of the ...

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...

Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Morgan Stanley from $70.00 to $38.00 in a report ...

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

If you’re on the fence about investing in Moderna, Inc., Sarepta Therapeutics or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...